Table 1.
Clinical and pathologic characteristics of 93 patients underwent total pancreatectomy.
| Characteristics | Total | NDG | With pre-op DM | P value | |
|---|---|---|---|---|---|
| SDG | LDG | ||||
| N | 93 (100) | 41 (44.1) | 22 (23.7) | 30 (32.3) | – |
| Age at operation (years) | 59.9 ± 10.8 | 57.8 ± 11.2 | 59.5 ± 12.6 | 62.9 ± 8.1# | 0.145 |
| Male | 43 (46.2) | 20 (48.8) | 9 (40.9) | 14 (46.7) | 0.835 |
| Pathology | 0.829 | ||||
| Pancreatic carcinoma | |||||
| Ductal adenocarcinoma | 35 (37.6) | 14 (34.1) | 11 (50.0) | 10 (33.3) | – |
| Acinar cell carcinoma | 2 (2.2) | 2 (4.9) | 0 | 0 | – |
| Adenosquamous carcinoma | 1 (1.1) | 0 | 0 | 1 (3.3) | – |
| IPMN | |||||
| Invasive IPMN | 21 (22.6) | 9 (22.0) | 5 (22.7) | 7 (23.3) | – |
| Non-invasive IPMN | 15 (16.1) | 5 (12.2) | 4 (18.2) | 6 (20.0) | – |
| PNET* | 8 (8.6) | 4 (9.8) | 1 (4.5) | 3 (10.0) | – |
| Cystic neoplasms | |||||
| Serous cystadenoma | 2 (2.2) | 0 | 1 (4.5) | 1 (3.3) | – |
| Mucous cystadenocarcinoma | 1 (1.1) | 1 (2.4) | 0 | 0 | – |
| Carcinosarcoma | 2 (2.2) | 2 (4.9) | 0 | 0 | – |
| Ampullary carcinoma | 2 (2.2) | 1 (2.4) | 0 | 1 (3.3) | – |
| Mixed ductal-endocrine carcinoma | 1 (1.1) | 1 (2.4) | 0 | 0 | – |
| Cholangiocarcinoma | 1 (1.1) | 0 | 0 | 1 (3.3) | – |
| Renal cell carcinoma metastasis | 1 (1.1) | 1 (2.4) | 0 | 0 | – |
| Malignant fibroma metastasis | 1 (1.1) | 1 (2.4) | 0 | 0 | – |
| Postoperative complications | 30 (32.3) | 13 (31.7) | 7 (31.8) | 10 (33.3) | 0.988 |
| Abdominal infection | 13 (14.0) | 6 (14.6) | 3 (13.6) | 4 (13.3) | – |
| Hospital acquired pneumonia | 6 (6.5) | 3 (7.3) | 3 (13.6) | 0 | – |
| Urinary infection | 2 (2.2) | 0 | 0 | 2 (6.7) | – |
| Catheter related infection | 1 (1.1) | 1 (2.4) | 0 | 0 | – |
| Abdominal hemorrhage | 9 (9.7) | 5 (12.2) | 1 (4.5) | 3 (10.0) | – |
| Delayed gastric emptying | 2 (2.2) | 1 (2.4) | 1 (4.5) | 0 | – |
| Deep venous thrombosis | 2 (2.2) | 2 (4.9) | 0 | 0 | – |
| Acute coronary syndrome | 2 (2.2) | 0 | 0 | 2 (6.7) | – |
| Chyle leak | 1 (1.1) | 1 (2.4) | 0 | 0 | – |
| Postoperative length of stay (days) | 14 (12, 23) | 15 (13, 28) | 13 (11, 19) | 15 (12, 19) | 0.318 |
Data are presented as mean ± SD or median (interquartile range) or number (percentage). pre-op, preoperative; DM, diabetes mellitus; NDG, nondiabetic group; SDG, short-duration diabetic group; LDG, long-duration diabetic group; IPMN, intraductal papillary mucinous neoplasm; PNET, pancreatic neuroendocrine tumor.
*Four patients with multiple endocrine neoplasia type 1.
#P < 0.05 vs NDG.